Clear Cell Renal Cell Carcinoma - 28 Studies Found
| Terminated |
: Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer :
: 2008-08-01 : |
| Completed |
: Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma : Clear Cell Renal Cell Carcinoma : 2005-09-12 :
|
| Completed |
: Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer :
: 2012-08-24 : |
| Completed |
: A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma :
|
| Recruiting |
: Trial of X4P-001 in Patients With Advanced Renal Cell Carcinoma : Clear Cell Renal Cell Carcinoma : 2016-01-20 :
|
| Completed |
: Investigating Patient Satisfaction With Oral Anti-Cancer Treatment : Clear Cell Renal Cell Carcinoma : 2014-07-03 |
| Completed |
: Value of Various Chemokines in the Detection and Follow up of RCC : Clear Cell Renal Cell Carcinoma : 2013-10-30 : Other: patients with renal cell carcinoma Chemokines that may be elevated in patients with RCC |
| Completed |
: 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC : Clear Cell Renal Cell Carcinoma : 2013-01-08 : Drug: Dovitinib Patients will be treated with dovitinib (5 |
| Completed |
: Phase II Study of Lutetium-177 Labeled Girentuximab in Patients With Advanced Renal Cancer : Metastatic Clear Cell Renal Cell Carcinoma : 2013-11-29 : Drug: Lu-177-DOTA-girentuximab Drug: In-111-DOTA-girentuxi |
| Terminated |
: Vandetanib to Treat Advanced Kidney Cancer : Advanced Clear Cell Renal Carcinoma : 2011-06-11 : Drug: vandetanib Daily dose 300mg/day by mouth, 28 day cycle |